The CooperMEX:COO 89 PB Ratio is 1.57 as of Jun. 25, 2026, which is 50% below its 10-year median of 3.14. GuruFocus rates MEX:COO with a GF Score™ of 89/100 and a GF Value™ of MXN1,702.46 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 788 Medical Devices & Instruments companies, The Cooper ranks better than 61.04% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), The Cooper's share price is MXN1162.20. The Cooper's Book Value per Share for the quarter that ended in Apr. 2026 was MXN740.40. Hence, The Cooper's PB Ratio of today is 1.57.
The historical rank and industry rank for The Cooper's PB Ratio or its related term are showing as below:
MEX:COO'
s PB Ratio Range Over the Past 10 Years
Min: 1.41 Med: 3.14 Max: 4.88
Current: 1.63
During the past 13 years, The Cooper's highest PB Ratio was 4.88. The lowest was 1.41. And the median was 3.14.
MEX:COO's PB Ratio is ranked better than 61.04% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs MEX:COO: 1.63
During the past 12 months, The Cooper's average Book Value Per Share Growth Rate was 1.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 13.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 14.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of The Cooper was 201.20% per year. The lowest was -83.20% per year. And the median was 10.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
The Cooper PB Ratio Related Terms
The Cooper PB Ratio Historical Data
* Premium members only.
The historical data trend for The Cooper's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, The Cooper's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's PB Ratio distribution charts can be found below:
* The bar in red indicates where The Cooper's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
The Cooper's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The Cooper (MEX:COO) has a PB Ratio of 1.57 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on The Cooper and its competitors. This is 50% below median its historical median of 3.14. Over the past decade, The Cooper's PB Ratio has ranged from 1.41 to 4.88. According to the industry distribution chart, The Cooper ranks #307 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 39%.
Is The Cooper's PB Ratio too high?
The Cooper's current PB Ratio of 1.57 is 50% below median its 10-year median of 3.14. Over the past 10 years, this metric has ranged from a low of 1.41 to a high of 4.88. The Medical Devices & Instruments industry median PB Ratio is 2.05. The Cooper's value of 1.57 is 23.2% below this industry median. Based on the distribution chart, The Cooper ranks #307 out of 788 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, The Cooper has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's PB Ratio compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, The Cooper ranks #307 out of 788 companies for PB Ratio. This puts The Cooper in the upper half of its industry. The industry median PB Ratio is 2.05. The Cooper's value of 1.57 is 23.2% below this benchmark. Historically, The Cooper's own PB Ratio has ranged from 1.41 to 4.88 over the past decade. While the company's 10-year median is 3.14 vs. the industry median of 2.05, The Cooper has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cooper's current PB Ratio of 1.57 is 23.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on The Cooper and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cooper's current PB Ratio is 1.57, which is 50% below median its own 10-year median of 3.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (MEX:COO) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,702.46, compared to a current price of MXN1,162.20 — trading 31.7% below its estimated fair value. The current PB Ratio is 1.57, which is 50% below median its 10-year median of 3.14 and 23.2% below the Medical Devices & Instruments industry median of 2.05. The Cooper's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For The Cooper (MEX:COO), the current PB Ratio is 1.57 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cooper (MEX:COO) Overvalued in 2026?
Based on GuruFocus' analysis, The Cooper stock appears to be undervalued.
The current stock price of MXN1,162.20 is trading 31.7% below its estimated GF Value™ of MXN1,702.46.
GuruFocus considers The Cooper to be Significantly Undervalued.
Key valuation signals for MEX:COO:
PB Ratio: 1.57 (50% below median its 10-year median of 3.14)
GF Value™: MXN1,702.46 vs. price of MXN1,162.20 (31.7% below fair value)
Industry Position: 23.2% below the Medical Devices & Instruments median (#307 of 788)
No single metric tells the full story. See the MEX:COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
89GF Score
Get the complete analysis for MEX:COO
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:COO has been successfully added to your 
